We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.23 | 0.53% | 43.58 | 43.68 | 43.27 | 43.58 | 4,048,068 | 01:00:00 |
From May 2019 to May 2024
By Chris Wack
Perrigo Company Plc (PRGO) said Thursday it is buying the branded over-the-counter rights to Prevacid from GlaxoSmithKline (GSK).
Perrigo said under the terms of the agreement, it will have the exclusive rights to market, sell and distribute Prevacid 24HR in the U.S. OTC market.
Financial terms of the agreement weren't disclosed.
Prevacid 24HR treats frequent heartburn occurring two or more days a week.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
September 05, 2019 09:09 ET (13:09 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
